Novartis AG
Stock Forecast, Prediction & Price Target
Novartis AG Financial Estimates
Novartis AG Revenue Estimates
Novartis AG EBITDA Estimates
Novartis AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF52.87B N/A | CHF51.82B -1.98% | CHF46.66B -9.97% | Avg: CHF51.26B Low: CHF51.26B High: CHF51.26B avg. 9.86% | Avg: CHF51.91B Low: CHF51.91B High: CHF51.91B avg. 1.27% | Avg: CHF47.20B Low: CHF47.20B High: CHF47.20B avg. -9.08% | Avg: CHF47.95B Low: CHF47.95B High: CHF47.95B avg. 1.59% |
Net Income
% change YoY
| CHF24.02B N/A | CHF6.95B -71.04% | CHF14.85B 113.51% | Avg: CHF11.69B Low: CHF11.95B High: CHF15.96B avg. -21.24% | Avg: CHF12.66B Low: CHF12.75B High: CHF16.93B avg. 8.27% | Avg: CHF18.86B Low: CHF18.86B High: CHF18.86B avg. 48.94% | Avg: CHF19.94B Low: CHF19.94B High: CHF19.94B avg. 5.71% |
EBITDA
% change YoY
| CHF33.06B N/A | CHF16.38B -50.42% | CHF18.25B 11.38% | Avg: CHF20.53B Low: CHF20.53B High: CHF20.53B avg. 12.49% | Avg: CHF20.79B Low: CHF20.79B High: CHF20.79B avg. 1.27% | Avg: CHF18.90B Low: CHF18.90B High: CHF18.90B avg. -9.08% | Avg: CHF19.21B Low: CHF19.21B High: CHF19.21B avg. 1.59% |
EPS
% change YoY
| $10.71 N/A | $3.19 -70.21% | $7.11 122.88% | Avg: $6.52 Low: $5.71 High: $7.63 avg. -8.31% | Avg: $7.13 Low: $6.1 High: $8.09 avg. 9.38% | Avg: $9.02 Low: $9.02 High: $9.02 avg. 26.44% | Avg: $9.53 Low: $9.53 High: $9.53 avg. 5.71% |
Operating Expenses
% change YoY
| CHF25.32B N/A | CHF27.14B 7.20% | CHF24.41B -10.04% | Avg: CHF14.39B Low: CHF14.39B High: CHF14.39B avg. -41.03% | Avg: CHF14.58B Low: CHF14.58B High: CHF14.58B avg. 1.27% | Avg: CHF13.25B Low: CHF13.25B High: CHF13.25B avg. -9.08% | Avg: CHF13.47B Low: CHF13.47B High: CHF13.47B avg. 1.59% |
FAQ
What is Novartis AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 10.42% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is 11.95B, average is 11.69B and high is 15.96B.
What is Novartis AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 0.91% in 2025-2028.
We have gathered data from 18 analysts. Their low revenue estimate is CHF51.26B, average is CHF51.26B and high is CHF51.26B.
What is Novartis AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 8.30% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is $5.71, average is $6.52 and high is CHF7.63.